Wednesday, December 23, 2009

Trigon Depot




Trigon Depot may be available in the countries listed below.


Ingredient matches for Trigon Depot



Triamcinolone

Triamcinolone 16α,17α-acetonide (a derivative of Triamcinolone) is reported as an ingredient of Trigon Depot in the following countries:


  • Spain

International Drug Name Search

Muxol




Muxol may be available in the countries listed below.


Ingredient matches for Muxol



Ambroxol

Ambroxol is reported as an ingredient of Muxol in the following countries:


  • Peru

  • Tunisia

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Muxol in the following countries:


  • Chile

  • France

  • Luxembourg

  • Peru

  • Romania

Bisacodyl

Bisacodyl is reported as an ingredient of Muxol in the following countries:


  • Switzerland

International Drug Name Search

Tuesday, December 22, 2009

Iporel




Iporel may be available in the countries listed below.


Ingredient matches for Iporel



Clonidine

Clonidine hydrochloride (a derivative of Clonidine) is reported as an ingredient of Iporel in the following countries:


  • Poland

International Drug Name Search

Sunday, December 20, 2009

Mianserine HCl katwijk




Mianserine HCl katwijk may be available in the countries listed below.


Ingredient matches for Mianserine HCl katwijk



Mianserin

Mianserin hydrochloride (a derivative of Mianserin) is reported as an ingredient of Mianserine HCl katwijk in the following countries:


  • Netherlands

International Drug Name Search

Friday, December 18, 2009

Gabapentina Winthrop




Gabapentina Winthrop may be available in the countries listed below.


Ingredient matches for Gabapentina Winthrop



Gabapentin

Gabapentin is reported as an ingredient of Gabapentina Winthrop in the following countries:


  • Spain

International Drug Name Search

Tuesday, December 15, 2009

Lostaprolol




Lostaprolol may be available in the countries listed below.


Ingredient matches for Lostaprolol



Bisoprolol

Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Lostaprolol in the following countries:


  • Argentina

International Drug Name Search

Phoenix Xylaket




Phoenix Xylaket may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Phoenix Xylaket



Ketamine

Ketamine hydrochloride (a derivative of Ketamine) is reported as an ingredient of Phoenix Xylaket in the following countries:


  • New Zealand

Xylazine

Xylazine hydrochloride (a derivative of Xylazine) is reported as an ingredient of Phoenix Xylaket in the following countries:


  • New Zealand

International Drug Name Search

Tuesday, December 8, 2009

Maalox Plus




In the US, Maalox Plus is a member of the drug class antacids and is used to treat Gas, GERD and Indigestion.

Ingredient matches for Maalox Plus



Aluminium Hydroxide

Aluminium Hydroxide is reported as an ingredient of Maalox Plus in the following countries:


  • Netherlands

Magnesium Hydroxide

Magnesium Hydroxide is reported as an ingredient of Maalox Plus in the following countries:


  • Netherlands

  • Slovakia

International Drug Name Search

Virbamec D




Virbamec D may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Virbamec D



Clorsulon

Clorsulon is reported as an ingredient of Virbamec D in the following countries:


  • France

Ivermectin

Ivermectin is reported as an ingredient of Virbamec D in the following countries:


  • France

International Drug Name Search

Blastolem




Blastolem may be available in the countries listed below.


Ingredient matches for Blastolem



Cisplatin

Cisplatin is reported as an ingredient of Blastolem in the following countries:


  • Chile

  • Mexico

  • Peru

International Drug Name Search

Unicontin




Unicontin may be available in the countries listed below.


Ingredient matches for Unicontin



Theophylline

Theophylline is reported as an ingredient of Unicontin in the following countries:


  • Bangladesh

  • India

  • Portugal

  • Sri Lanka

International Drug Name Search

Friday, December 4, 2009

Tenzimet




Tenzimet may be available in the countries listed below.


Ingredient matches for Tenzimet



Clopamide

Clopamide is reported as an ingredient of Tenzimet in the following countries:


  • Slovenia

Pindolol

Pindolol is reported as an ingredient of Tenzimet in the following countries:


  • Slovenia

International Drug Name Search

Thursday, November 26, 2009

Fraurs




Fraurs may be available in the countries listed below.


Ingredient matches for Fraurs



Ursodeoxycholic Acid

Ursodeoxycholic Acid is reported as an ingredient of Fraurs in the following countries:


  • Italy

International Drug Name Search

Sunday, November 15, 2009

Mutose




Mutose may be available in the countries listed below.


Ingredient matches for Mutose



Streptokinase

Streptokinase is reported as an ingredient of Mutose in the following countries:


  • Vietnam

International Drug Name Search

Friday, November 13, 2009

Pharmaniaga Gilbenclamide




Pharmaniaga Gilbenclamide may be available in the countries listed below.


Ingredient matches for Pharmaniaga Gilbenclamide



Glibenclamide

Glibenclamide is reported as an ingredient of Pharmaniaga Gilbenclamide in the following countries:


  • Malaysia

International Drug Name Search

Itranazole




Itranazole may be available in the countries listed below.


Ingredient matches for Itranazole



Itraconazole

Itraconazole is reported as an ingredient of Itranazole in the following countries:


  • Bulgaria

International Drug Name Search

Afumix




Afumix may be available in the countries listed below.


Ingredient matches for Afumix



Fluconazole

Fluconazole is reported as an ingredient of Afumix in the following countries:


  • Peru

Tinidazole

Tinidazole is reported as an ingredient of Afumix in the following countries:


  • Peru

International Drug Name Search

Thursday, November 12, 2009

Vetiprost




Vetiprost may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vetiprost



Etiproston

Etiproston is reported as an ingredient of Vetiprost in the following countries:


  • Netherlands

Finasteride

Finasteride is reported as an ingredient of Vetiprost in the following countries:


  • Argentina

  • Peru

International Drug Name Search

Auradol




Auradol may be available in the countries listed below.


Ingredient matches for Auradol



Frovatriptan

Frovatriptan succinate monohydrate (a derivative of Frovatriptan) is reported as an ingredient of Auradol in the following countries:


  • Italy

International Drug Name Search

Saturday, October 24, 2009

Dologesic


Pronunciation: ah-seet-ah-MIN-oh-fen/fen-ill-tole-OX-a-meen
Generic Name: Acetaminophen/Phenyltoloxamine
Brand Name: Examples include Acuflex and Dologesic


Dologesic is used for:

Treating mild to moderate aches and pains associated with headache, muscle and joint soreness, backache, menstrual cramps, colds and flu, sinusitis, toothache, and minor pain from arthritis, and to reduce fever. It may also be used for other conditions as determined by your doctor.


Dologesic is an analgesic, antihistamine, and antipyretic combination. It works by blocking substances in the body that cause fever, pain, and inflammation. It also blocks histamine, which causes sneezing and itchy, watery eyes.


Do NOT use Dologesic if:


  • you are allergic to any ingredient in Dologesic

  • you are taking sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Dologesic:


Some medical conditions may interact with Dologesic. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have bleeding problems, blood vessel problems in the brain, a blockage of the stomach or bowel, a blockage of the bladder, or difficulty urinating

  • if you have lung problems (eg, asthma, emphysema, chronic obstructive pulmonary disease [COPD]), an enlarged prostate, glaucoma, kidney problems, or liver problems

Some MEDICINES MAY INTERACT with Dologesic. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Isoniazid, monoamine oxidase (MAO) inhibitors (eg, phenelzine), or sodium oxybate (GHB) because the risk of side effects may be increased

  • Anticoagulants (eg, warfarin) because the risk of side effects, including the risk of bruising or bleeding, may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dologesic may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Dologesic:


Use Dologesic as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Dologesic may be taken with or without food.

  • If you miss a dose of Dologesic and you are using it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dologesic.



Important safety information:


  • Dologesic may cause drowsiness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Dologesic. Using Dologesic alone, with certain other medicines, or with alcohol may lessen your ability to drive or perform other potentially dangerous tasks.

  • Dologesic contains acetaminophen. Before you begin taking any new prescription or nonprescription medicine, read the ingredients to see if it also contains acetaminophen. If it does or if you are uncertain, contact your doctor or pharmacist.

  • Avoid taking medicines that cause drowsiness (eg, sedatives, tranquilizers) while taking Dologesic. Dologesic will add to the effects of alcohol and other depressants. Ask your pharmacist if you have questions about which medicines are depressants.

  • Do not exceed the recommended dosage or take Dologesic for longer than prescribed without checking with your doctor.

  • If you consume 3 or more alcohol-containing drinks every day, ask your doctor whether you should take Dologesic or other pain relievers/fever reducers. Acetaminophen may cause liver damage. Alcohol use combined with Dologesic may increase your risk for liver damage.

  • If you are taking Dologesic for pain or fever and your symptoms do not improve within 10 days or if they become worse, check with your doctor.

  • Before you have any medical or dental treatments or surgery, tell the doctor or dentist that you are taking Dologesic.

  • Caution is advised when using Dologesic in CHILDREN because they may be more sensitive to its effects.

  • PREGNANCY and BREAST-FEEDING: It is unknown if Dologesic can cause harm to the fetus. If you become pregnant, discuss with your doctor the benefits and risks of using Dologesic during pregnancy. Dologesic is excreted in breast milk. Do not breast-feed while taking Dologesic.


Possible side effects of Dologesic:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Drowsiness; dry mouth, nose, or throat; heartburn; nausea; thickening of mucus in the nose and throat; upset stomach.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; dark urine or pale stools; decreased urination; severe stomach pain; unusual bruising or bleeding; unusual tiredness; vomiting; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Dologesic side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include abnormal behavior; dark urine; excessive sweating; extreme tiredness; fast or deep breathing; loss of consciousness; ringing in the ears; stomach pain; vomiting.


Proper storage of Dologesic:

Store Dologesic at room temperature, 77 degrees F (25 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dologesic out of the reach of children and away from pets.


General information:


  • If you have any questions about Dologesic, please talk with your doctor, pharmacist, or other health care provider.

  • Dologesic is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dologesic. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dologesic resources


  • Dologesic Side Effects (in more detail)
  • Dologesic Use in Pregnancy & Breastfeeding
  • Dologesic Drug Interactions
  • Dologesic Support Group
  • 0 Reviews for Dologesic - Add your own review/rating


  • Acuflex Consumer Overview

  • Percogesic Consumer Overview



Compare Dologesic with other medications


  • Cold Symptoms
  • Headache
  • Influenza
  • Pain

Monday, October 19, 2009

Aprost




Aprost may be available in the countries listed below.


Ingredient matches for Aprost



Finasteride

Finasteride is reported as an ingredient of Aprost in the following countries:


  • Poland

International Drug Name Search

Glitral




Glitral may be available in the countries listed below.


Ingredient matches for Glitral



Glibenclamide

Glibenclamide is reported as an ingredient of Glitral in the following countries:


  • Argentina

International Drug Name Search

Sunday, October 18, 2009

Livarole




Livarole may be available in the countries listed below.


Ingredient matches for Livarole



Ketoconazole

Ketoconazole is reported as an ingredient of Livarole in the following countries:


  • Russian Federation

International Drug Name Search

Thursday, October 15, 2009

Klabion




Klabion may be available in the countries listed below.


Ingredient matches for Klabion



Clarithromycin

Clarithromycin is reported as an ingredient of Klabion in the following countries:


  • Poland

International Drug Name Search

Glimexal




Glimexal may be available in the countries listed below.


Ingredient matches for Glimexal



Glimepiride

Glimepiride is reported as an ingredient of Glimexal in the following countries:


  • Indonesia

International Drug Name Search

Wednesday, October 14, 2009

Rigevidon




Rigevidon may be available in the countries listed below.


Ingredient matches for Rigevidon



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Rigevidon in the following countries:


  • Bulgaria

  • Denmark

  • Hungary

  • Latvia

  • Lithuania

  • Poland

  • Slovenia

  • Venezuela

  • Vietnam

Levonorgestrel

Levonorgestrel is reported as an ingredient of Rigevidon in the following countries:


  • Bulgaria

  • Denmark

  • Hungary

  • Latvia

  • Lithuania

  • Poland

  • Slovenia

  • Venezuela

  • Vietnam

International Drug Name Search

Monday, October 12, 2009

Xylocaïne




Xylocaïne may be available in the countries listed below.


Ingredient matches for Xylocaïne



Lidocaine

Lidocaine is reported as an ingredient of Xylocaïne in the following countries:


  • Tunisia

Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Xylocaïne in the following countries:


  • France

Lidocaine hydrochloride monohydrate (a derivative of Lidocaine) is reported as an ingredient of Xylocaïne in the following countries:


  • France

International Drug Name Search

Sunday, October 11, 2009

Proguanil




In the US, Proguanil (proguanil systemic) is a member of the drug class miscellaneous antimalarials.

US matches:

  • Proguanil

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

P01BB01

CAS registry number (Chemical Abstracts Service)

0000500-92-5

Chemical Formula

C11-H16-Cl-N5

Molecular Weight

253

Therapeutic Category

Antiprotozoal agent: Antimalarial

Chemical Name

Imidodicarbonimidic diamide, N-(4-chlorophenyl)-N'-(1-methylethyl)-

Foreign Names

  • Proguanilum (Latin)
  • Proguanil (German)
  • Proguanil (French)
  • Proguanil (Spanish)

Generic Names

  • Proguanil (OS: BAN, DCF)
  • Chloriguane (IS)
  • PR 3359 (IS)
  • Proguanide (IS)
  • SN 12837 (IS)
  • Proguanil Hydrochloride (OS: BANM, USAN)
  • Bigumalum (IS)
  • Chloroguanide Hydrochloride (IS)
  • Chloroguanide Hydrochloride (PH: USP XIV)
  • Proguanil Hydrochloride (PH: Ph. Eur. 6, Ph. Int. 4, BP 2010)
  • Proguanile cloridrato (PH: F.U. IX)
  • Proguanili hydrochloridum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

  • Malarone (Proguanil and Atovaquone)
    GlaxoSmithKline, Hungary; GlaxoSmithKline, Slovenia


  • Laveran
    Unicure, India


  • Malarone (Proguanil and Atovaquone)
    Dr. Fisher, Netherlands; Eureco, Netherlands; Glaxo SmithKline, Spain; GlaxoSmithKline, Austria; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Denmark; GlaxoSmithKline, Estonia; GlaxoSmithKline, Finland; GlaxoSmithKline, France; GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Ireland; GlaxoSmithKline, Italy; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Netherlands; GlaxoSmithKline, Norway; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, United States


  • Malarone Junior (Proguanil and Atovaquone (pediatric))
    GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, Switzerland; GlaxoSmithKline, Germany; GlaxoSmithKline, Norway; GlaxoSmithKline, Sweden


  • Malarone Paediatric (Proguanil and Atovaquone (pediatric))
    GlaxoSmithKline, United Kingdom; GlaxoSmithKline, Greece


  • Melanil (Proguanil and Atovaquone)
    GlaxoSmithKline, South Africa


  • Paludrine
    AstraZeneca, United Arab Emirates; AstraZeneca, Australia; AstraZeneca, Belgium; AstraZeneca, Bahrain; AstraZeneca, Cyprus; AstraZeneca, Germany; AstraZeneca, Egypt; AstraZeneca, Ethiopia; AstraZeneca, France; AstraZeneca, United Kingdom; AstraZeneca, Ghana; AstraZeneca, Israel; AstraZeneca, Iraq; AstraZeneca, Italy; AstraZeneca, Jordan; AstraZeneca, Kenya; AstraZeneca, Kuwait; AstraZeneca, Lebanon; AstraZeneca, Luxembourg; AstraZeneca, Libya; AstraZeneca, Malawi; AstraZeneca, Mozambique; AstraZeneca, Nigeria; AstraZeneca, Netherlands; AstraZeneca, Portugal; AstraZeneca, Qatar; AstraZeneca, Saudi Arabia; AstraZeneca, Sudan; AstraZeneca, Syria; AstraZeneca, Tanzania; AstraZeneca, Uganda; AstraZeneca, Yemen; AstraZeneca, Zambia; AstraZeneca, Zimbabwe; Dr. Fisher, Netherlands; EU-Pharma, Netherlands; Euro, Netherlands; Medcor, Netherlands

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, October 8, 2009

Flomedil




Flomedil may be available in the countries listed below.


Ingredient matches for Flomedil



Buflomedil

Buflomedil is reported as an ingredient of Flomedil in the following countries:


  • Tunisia

International Drug Name Search

Thursday, October 1, 2009

Alstat




Alstat may be available in the countries listed below.


Ingredient matches for Alstat



Etamsylate

Etamsylate is reported as an ingredient of Alstat in the following countries:


  • India

International Drug Name Search

Friday, September 25, 2009

Despa




Despa may be available in the countries listed below.


Ingredient matches for Despa



Chlorhexidine

Chlorhexidine dihydrochloride (a derivative of Chlorhexidine) is reported as an ingredient of Despa in the following countries:


  • Japan

Diphenhydramine

Diphenhydramine is reported as an ingredient of Despa in the following countries:


  • Japan

International Drug Name Search

Wednesday, September 16, 2009

Ranitidina Pliva




Ranitidina Pliva may be available in the countries listed below.


Ingredient matches for Ranitidina Pliva



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitidina Pliva in the following countries:


  • Italy

International Drug Name Search

Thursday, September 10, 2009

Ranitac




Ranitac may be available in the countries listed below.


Ingredient matches for Ranitac



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitac in the following countries:


  • Japan

International Drug Name Search

Tuesday, September 8, 2009

Arcalyst




In the US, Arcalyst (rilonacept systemic) is a member of the drug class interleukin inhibitors and is used to treat Cryopyrin-Associated Periodic Syndromes, Familial Cold Autoinflammatory Syndrome and Muckle Wells Syndrome.

US matches:

  • Arcalyst

Ingredient matches for Arcalyst



Rilonacept

Rilonacept is reported as an ingredient of Arcalyst in the following countries:


  • United States

International Drug Name Search

Saturday, September 5, 2009

Carcinoid Tumor Medications


Drugs associated with Carcinoid Tumor

The following drugs and medications are in some way related to, or used in the treatment of Carcinoid Tumor. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

Learn more about Carcinoid Tumor





Drug List:

Pseudofrin




Pseudofrin may be available in the countries listed below.


Ingredient matches for Pseudofrin



Pseudoephedrine

Pseudoephedrine hydrochloride (a derivative of Pseudoephedrine) is reported as an ingredient of Pseudofrin in the following countries:


  • Canada

International Drug Name Search

Friday, August 21, 2009

Ceftriaxone Teva




Ceftriaxone Teva may be available in the countries listed below.


Ingredient matches for Ceftriaxone Teva



Ceftriaxone

Ceftriaxone is reported as an ingredient of Ceftriaxone Teva in the following countries:


  • Poland

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Ceftriaxone Teva in the following countries:


  • France

  • Israel

  • Italy

International Drug Name Search

Tuesday, August 18, 2009

Benztropine Mesylate



Class: Anticholinergic Agents
VA Class: AU350
CAS Number: 132-17-2
Brands: Cogentin

Introduction

Antimuscarinic antiparkinsonian agent.


Uses for Benztropine Mesylate


Parkinsonian Syndrome


Adjunctive treatment of all forms of parkinsonian syndrome.a


May be used as monotherapy or combined with other antiparkinsonian agents (e.g., carbidopa-levodopa).a b


Drug-Induced Extrapyramidal Reactions


Control of extrapyramidal reactions (e.g., acute dystonia) induced by antipsychotic agents (e.g., phenothiazines).a


Does not alleviate symptoms of tardive dyskinesia, and in some instances may aggravate them.a b c Use not recommended.a b c


Benztropine Mesylate Dosage and Administration


Administration


Administered orally or by IM injection.a b


Also may be given IV.b Onset is rapid after either IM or IV injection, with no important difference in onset.b Manufacturer states there usually is no need to administer IV and does not provide specific instructions for IV administration.b


Oral Administration


Administered as a single dose at bedtime or in divided doses 2–4 times daily.a b


IM Administration


Reserve for patients who cannot take oral medication or for emergency situations (e.g., acute dystonia).a b


Dosage


Available as benztropine mesylate; dosage is expressed in terms of the salt.a b


Geriatric patients or those with less than average body weight generally cannot tolerate high dosages of the drug.a b


Pediatric Patients


Manufacturers make no specific dosage recommendations for children ≥ 3 years of age.a b (See Pediatric Use under Cautions.)


Adults


Parkinsonian Syndrome

May require periodic dosage adjustments to maintain optimum symptomatic relief in patients receiving concomitant levodopa or combination levodopa-carbidopa therapy.a


If used to replace or supplement other antiparkinsonian drugs, change should be gradual, with dosage of previous medication reduced as benztropine dosage is increased.a


Avoid abrupt discontinuance of concomitantly administered antiparkinsonian drugs.a


Idiopathic Parkinsonian Syndrome

Oral

Initially, 0.5–1 mg as a single dose at bedtime.b Dosages may be increased by 0.5-mg increments at 5–6 day intervals up to a maximum of 6 mg daily.b


Usual dosage: 1–2 mg daily (range: 0.5–6 mg daily).b


IM

Initially, 0.5–1 mg as a single dose at bedtime.a Dosages may be increased by 0.5-mg increments at 5- to 6-day intervals up to a maximum of 6 mg daily.a


Usual dosage: 1–2 mg daily (range: 0.5–6 mg daily).a b


Postencephalitic Parkinsonian Syndrome

Oral

Initially, 2 mg daily, given in 1 or more divided doses.b In highly sensitive patients, may give instead as a single 0.5 mg dose at bedtime.b Dosages may be increased by 0.5-mg increments at 5- to 6-day intervals up to a maximum of 6 mg daily.b


Usual dosage: 1–2 mg daily (range: 0.5–6 mg daily).b


IM

Initially, 2 mg daily, given in 1 or more divided doses.a In highly sensitive patients, may give instead as a single 0.5 mg dose at bedtime.a Dosages may be increased by 0.5-mg increments at 5–6 day intervals up to a maximum of 6 mg daily.a


Usual dosage: 1–2 mg daily (range: 0.5–6 mg daily).a


Drug-Induced Extrapyramidal Reactions

Oral

1–4 mg once or twice daily.b


For extrapyramidal disorders that develop shortly after initiation of antipsychotic therapy, 1–2 mg 2 or 3 times daily usually provides relief within 1 or 2 days.b Evaluate need for continued therapy after 1–2 weeks.b


IM

1–4 mg once or twice daily.a


For extrapyramidal disorders that develop shortly after initiation of antipsychotic therapy, 1–2 mg 2 or 3 times daily usually provides relief within 1 or 2 days.a Evaluate need for continued therapy after 1–2 weeks.a


Acute Dystonia

IM

1–2 mg, as a single dose.a


Prescribing Limits


Adults


Parkinsonian Syndrome

Oral

Maximum 6 mg daily.b


IM

Maximum 6 mg daily.a


Cautions for Benztropine Mesylate


Contraindications



  • Known hypersensitivity to benztropine or any ingredient in the formulation.a b




  • Children < 3 years of age.a b



Warnings/Precautions


Warnings


Pregnancy

Safe use during pregnancy has not been established.a b


Cognitive/Physical Impairment

Risk of impaired mental alertness or physical coordination required for performing hazardous tasks (e.g., driving or operating machinery).a b


Drug Interactions

Concomitant use with phenothiazines or tricyclic antidepressants associated with potentially fatal paralytic ileus, hyperthermia, or heat stoke.a b Advise patients to promptly notify clinicians if adverse GI effects, fever, or heat intolerance occur if used concomitantly with these drugs or other drugs with anticholinergic or antidopaminergic (e.g., haloperidol) effects.a b (See Interactions.)


Anhidrosis

Possibly severe anhidrosis and fatal hyperthermia.a b Use with caution in hot weather, particularly when given concomitantly with other anticholinergic drugs to chronically ill or alcoholic patients, those who have CNS disease, and those engaged in manual labor.a b Decrease dosages as needed to maintain ability to perspire.a b


General Precautions


Adequate Patient Monitoring

Has cumulative effects; continue to monitor patients, particularly those with tendency toward tachycardia or with prostatic hypertrophy.a b


Musculoskeletal Effects

Possible complaints of weakness and inability to move particular muscle groups, particularly at large dosages; adjust dosages as required.a b


CNS Effects

Possible mental confusion and excitement, particularly with large dosages or in susceptible patients.a b Visual hallucinations also possible.a b (See Dosage and Administration: Dosage.)


Risk of intensification of mental symptoms or precipitation of toxic psychosis in patients with mental disorders receiving phenothiazines, especially at beginning of therapy or during dosage adjustment; monitor closely.a b (See Specific Drugs under Interactions.)


Tardive Dyskinesia

Not recommended for use in patients with tardive dyskinesia.a b (See Drug-Induced Extrapyramidal Reactions under Uses.)


Renal Effects

Possible dysuria or urinary retention.a b


Glaucoma

Consider risks of glaucoma.a b Probably should not be used in patients with angle-closure glaucoma.a b e


Specific Populations


Pregnancy

Category C.d See Warnings under Cautions.


Pediatric Use

Safety and efficacy not established in children <3 years of age.a b (See Cautions: Contraindications.)


Use with caution in children >3 years of age because of adverse anticholinergic effects.a b


Common Adverse Effects


Dry mouth, blurred vision, mydriasis, nausea, nervousness, tachycardia, paralytic ileus, constipation.c e


Interactions for Benztropine Mesylate


Specific Drugs


















Drug



Interaction



Comments



Anticholinergic agents



Increased risk of adverse anticholinergic effectsa b



Antidepressants, tricyclics



Potentially fatal paralytic ileus, hyperthermia, or heat intolerancea b



Advise patients to promptly notify clinicians if adverse GI effects, fever, or heat intolerance occursa b



Haloperidol



Potentially fatal paralytic ileus, hyperthermia, or heat intolerancea b



Advise patients to promptly notify clinicians if adverse GI effects, fever, or heat intolerance occursa b



Phenothiazines



Potentially fatal paralytic ileus, hyperthermia, or heat intolerancea b


Possible intensification of mental symptoms or precipitation of toxic psychosis in patients with mental disordersa b



Advise patients to promptly notify clinicians if adverse GI effects, fever, or heat intolerance occursa b


Observe carefully, especially at beginning of therapy or during dosage adjustmenta b


Stability


Storage


Oral


Tablets

< 30°C.b


Parenteral


Solution

< 40°C, preferably between 15–30°C; avoid freezing.c


Compatibility


For information on systemic interactions resulting from concomitant use, see Interactions.


Drug Compatibility


For information on IV injection of benztropine, see Administration under Dosage and Administration.






Y-Site CompatibilityHID

Compatible



Fluconazole



Tacrolimus










Compatibility in SyringeHID

Compatible



Chlorpromazine HCl



Fluphenazine HCl



Metoclopramide HCl



Perphenazine



Variable



Haloperidol lactate


ActionsActions



  • Possesses both anticholinergic and antihistaminic effects, although only the former have been established as therapeutically important in management of parkinsonism.a



Advice to Patients



  • Potential for drug to impair mental alertness or physical coordination; use caution when driving or operating machinery until effects on individual are known.a b




  • Risk of hyperthermia.a b




  • Importance of promptly notifying clinicians of adverse GI effects, fever, or heat intolerance, particularly if also receiving phenothiazines, haloperidol, or other drugs with anticholinergic or antidopaminergic activity.a b




  • Importance of women informing their clinician if they are or plan to become pregnant or paln to breast-feed.a b




  • Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs, as well as concomitant illnesses.a b




  • Importance of informing patients of other important precautionary information.a b (See Cautions.)



Preparations


Excipients in commercially available drug preparations may have clinically important effects in some individuals; consult specific product labeling for details.


* available from one or more manufacturer, distributor, and/or repackager by generic (nonproprietary) name




























Benztropine Mesylate

Routes



Dosage Forms



Strengths



Brand Names



Manufacturer



Oral



Tablets



0.5 mg*



Benztropine Mesylate Tablets



Corepharma, Par, Pliva, Rising Pharmaceuticals, Upsher-Smith



1 mg*



Benztropine Mesylate Tablets



Corepharma, Par, Pliva, Rising Pharmaceuticals, Upsher-Smith



2 mg*



Benztropine Mesylate Tablets



Corepharma, Par, Pliva, Rising Pharmaceuticals, Upsher-Smith



Parenteral



Injection



1 mg/mL



Cogentin (with sodium chloride 9 mg/mL)



Ovation


Comparative Pricing


This pricing information is subject to change at the sole discretion of DS Pharmacy. This pricing information was updated 03/2011. Actual costs to patients will vary depending on the use of specific retail or mail-order locations and health insurance copays.


Benztropine Mesylate 0.5MG Tablets (TEVA PHARMACEUTICALS USA): 60/$15.99 or 90/$17.99


Benztropine Mesylate 1MG Tablets (UPSHER-SMITH): 60/$15.99 or 90/$17.99


Benztropine Mesylate 2MG Tablets (UPSHER-SMITH): 90/$22.99 or 180/$45.97



Disclaimer

This report on medications is for your information only, and is not considered individual patient advice. Because of the changing nature of drug information, please consult your physician or pharmacist about specific clinical use.


The American Society of Health-System Pharmacists, Inc. and Drugs.com represent that the information provided hereunder was formulated with a reasonable standard of care, and in conformity with professional standards in the field. The American Society of Health-System Pharmacists, Inc. and Drugs.com make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information and specifically disclaims all such warranties. Users are advised that decisions regarding drug therapy are complex medical decisions requiring the independent, informed decision of an appropriate health care professional, and the information is provided for informational purposes only. The entire monograph for a drug should be reviewed for a thorough understanding of the drug's actions, uses and side effects. The American Society of Health-System Pharmacists, Inc. and Drugs.com do not endorse or recommend the use of any drug. The information is not a substitute for medical care.

AHFS Drug Information. © Copyright, 1959-2011, Selected Revisions October 2007. American Society of Health-System Pharmacists, Inc., 7272 Wisconsin Avenue, Bethesda, Maryland 20814.




References



a. Merck & Co., Inc., Cogentin (benztropine mesylate) injection prescribing information. Whitehouse Station, NJ; 2001 Oct.



b. Par pharmaceuticals, Inc., Benztropine mesylate tablets, USP prescribing information. Spring Valley, NY; 2001 Oct.



c. AHFS drug information 2003. McEvoy GK, ed. Benztropine mesylate. Bethesda, MD: American Society of Health-System Pharmacists; 2003:1185-6.



d. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 6th ed. Baltimore, MD: Williams & Wilkins; 2002:125-6.



e. AHFS drug information 2003. McEvoy GK, ed. Antimuscarinics/Antispasmodics General Statement. Bethesda, MD: American Society of Health-System Pharmacists; 2003:1188-96.



HID. Trissel LA. Handbook on injectable drugs. 14th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2007:205-6.



More Benztropine Mesylate resources


  • Benztropine Mesylate Side Effects (in more detail)
  • Benztropine Mesylate Use in Pregnancy & Breastfeeding
  • Drug Images
  • Benztropine Mesylate Drug Interactions
  • Benztropine Mesylate Support Group
  • 3 Reviews for Benztropine Mesylate - Add your own review/rating


  • Benztropine Prescribing Information (FDA)

  • Benztropine MedFacts Consumer Leaflet (Wolters Kluwer)

  • benztropine Concise Consumer Information (Cerner Multum)

  • benztropine Advanced Consumer (Micromedex) - Includes Dosage Information

  • Cogentin Prescribing Information (FDA)



Compare Benztropine Mesylate with other medications


  • Extrapyramidal Reaction
  • Parkinson's Disease

Saturday, August 15, 2009

Lisinopril-ratiopharm comp.




Lisinopril-ratiopharm comp. may be available in the countries listed below.


Ingredient matches for Lisinopril-ratiopharm comp.



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Lisinopril-ratiopharm comp. in the following countries:


  • Germany

Lisinopril

Lisinopril dihydrate (a derivative of Lisinopril) is reported as an ingredient of Lisinopril-ratiopharm comp. in the following countries:


  • Germany

International Drug Name Search

Friday, August 14, 2009

Doxiten Bio




Doxiten Bio may be available in the countries listed below.


Ingredient matches for Doxiten Bio



Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxiten Bio in the following countries:


  • Spain

International Drug Name Search

Monday, August 3, 2009

Serevent Inhaler




Serevent Inhaler may be available in the countries listed below.


Ingredient matches for Serevent Inhaler



Salmeterol

Salmeterol xinafoate (a derivative of Salmeterol) is reported as an ingredient of Serevent Inhaler in the following countries:


  • New Zealand

International Drug Name Search

Saturday, July 18, 2009

Amoxicillina EG




Amoxicillina EG may be available in the countries listed below.


Ingredient matches for Amoxicillina EG



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicillina EG in the following countries:


  • Italy

International Drug Name Search

Tuesday, July 7, 2009

Robitussin Nasal Relief


Generic Name: acetaminophen and phenylephrine (a SEET a MIN oh fen and FEN il EFF rin)

Brand Names: Alka-Seltzer Plus Cold and Sinus, Excedrin Sinus Headache Caplet, Mapap Sinus Congestion and Pain, Robitussin Nasal Relief, Sinus Congestion and Pain Daytime Cool Ice, Sinus Pain & Pressure, Sudafed PE Sinus Headache, Theraflu Daytime Severe Cold, Tylenol Sinus Congestion Daytime


What is Robitussin Nasal Relief (acetaminophen and phenylephrine)?

Acetaminophen is a pain reliever and a fever reducer.


Phenylephrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


The combination of acetaminophen and phenylephrine is used to treat headache, fever, body aches, stuffy nose, and sinus congestion caused by allergies, the common cold, or the flu.


Acetaminophen and phenylephrine may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Robitussin Nasal Relief (acetaminophen and phenylephrine)?


Do not take more of this medication than is recommended. An overdose of acetaminophen can damage your liver or cause death. Do not take this medication without a doctor's advice if you have ever had alcoholic liver disease (cirrhosis) or if you drink more than 3 alcoholic beverages per day. Do not use this medicine if you have untreated or uncontrolled diseases such as glaucoma, asthma or COPD, high blood pressure, heart disease, coronary artery disease, or overactive thyroid. Avoid drinking alcohol. It may increase your risk of liver damage while taking acetaminophen. Do not use acetaminophen and phenylephrine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects. Ask a doctor or pharmacist before using any other pain, cold, allergy, or sleep medication. Acetaminophen (sometimes abbreviated as APAP) is contained in many combination medicines. Taking certain products together can cause you to get too much acetaminophen which can lead to a fatal overdose. Check the label to see if a medicine contains acetaminophen or APAP.

What should I discuss with my healthcare provider before taking Robitussin Nasal Relief (acetaminophen and phenylephrine)?


Do not take this medication without a doctor's advice if you have ever had alcoholic liver disease (cirrhosis) or if you drink more than 3 alcoholic beverages per day. You may not be able to take acetaminophen. Do not use this medicine if you have untreated or uncontrolled diseases such as glaucoma, asthma or COPD, high blood pressure, heart disease, coronary artery disease, or overactive thyroid. Do not use this medicine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Ask a doctor or pharmacist if it is safe for you to take this medicine if you have:



  • liver disease, cirrhosis, or a history of alcoholism;




  • diabetes;




  • glaucoma;




  • epilepsy or other seizure disorder;




  • enlarged prostate or urination problems; or




  • pheochromocytoma (an adrenal gland tumor).




It is not known whether acetaminophen and phenylephrine will harm an unborn baby. Do not use this medicine without a doctor's advice if you are pregnant. Acetaminophen and phenylephrine may pass into breast milk and may harm a nursing baby. Decongestants may also slow breast milk production. Do not use this medicine without a doctor's advice if you are breast-feeding a baby.

How should I take Robitussin Nasal Relief (acetaminophen and phenylephrine)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. This medicine is usually taken only for a short time until your symptoms clear up.


Do not take more of this medication than is recommended. An overdose of acetaminophen can damage your liver or cause death. Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children.

Dissolve one packet of the powder in at least 4 ounces of water. Stir this mixture and drink all of it right away.


Drop the effervescent tablets into a glass of water (at least 4 ounces, or one-half cup). Stir this mixture and drink all of it right away.


Do not take for longer than 7 days in a row. Stop taking the medicine and call your doctor if you still have a fever after 3 days of use, you still have pain after 7 days (or 5 days if treating a child), if your symptoms get worse, or if you have a skin rash, ongoing headache, or any redness or swelling. If you need surgery or medical tests, tell the surgeon or doctor ahead of time if you have taken this medicine within the past few days. Store at room temperature away from moisture and heat.

What happens if I miss a dose?


Since this medicine is taken when needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of acetaminophen can be fatal.

The first signs of an acetaminophen overdose include loss of appetite, nausea, vomiting, stomach pain, sweating, and confusion or weakness. Later symptoms may include pain in your upper stomach, dark urine, and yellowing of your skin or the whites of your eyes.


Overdose symptoms may also include severe forms of some of the side effects listed in this medication guide.


What should I avoid while taking Robitussin Nasal Relief (acetaminophen and phenylephrine)?


Ask a doctor or pharmacist before using any other cold, allergy, pain, or sleep medication. Acetaminophen (sometimes abbreviated as APAP) is contained in many combination medicines. Taking certain products together can cause you to get too much acetaminophen which can lead to a fatal overdose. Check the label to see if a medicine contains acetaminophen or APAP. Avoid drinking alcohol. It may increase your risk of liver damage while you are taking acetaminophen. This medicine may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.

Robitussin Nasal Relief (acetaminophen and phenylephrine) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have a serious side effect such as:

  • chest pain, fast, slow, or uneven heart rate;




  • confusion, hallucinations;




  • tremor, seizure (convulsions);




  • urinating less than usual or not at all;




  • nausea, pain in your upper stomach, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of your skin or eyes); or




  • dangerously high blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, chest pain, uneven heartbeats, seizure).



Less serious side effects may include:



  • dizziness, weakness;




  • mild headache;




  • mild nausea, diarrhea, upset stomach;




  • runny nose;




  • feeling nervous, restless, or anxious; or




  • sleep problems (insomnia).



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Robitussin Nasal Relief (acetaminophen and phenylephrine)?


Ask a doctor or pharmacist if it is safe for you to take acetaminophen and phenylephrine if you are also using any of the following drugs:



  • leflunomide (Arava);




  • an antibiotic, antifungal medicine, sulfa drug, or tuberculosis medicine;




  • birth control pills or hormone replacement therapy;




  • blood pressure medication;




  • cancer medicine;




  • cholesterol-lowering medications such as Lipitor, Niaspan, Zocor, Vytorin, and others;




  • gout or arthritis medications (including gold injections);




  • HIV/AIDS medication;




  • medicines to treat psychiatric disorders;




  • an NSAID such as Advil, Aleve, Arthrotec, Cataflam, Celebrex, Indocin, Motrin, Naprosyn, Treximet, Voltaren, others; or




  • seizure medication.



This list is not complete and other drugs may interact with acetaminophen and phenylephrine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Robitussin Nasal Relief resources


  • Robitussin Nasal Relief Use in Pregnancy & Breastfeeding
  • Robitussin Nasal Relief Drug Interactions
  • 0 Reviews for Robitussin Nasal Relief - Add your own review/rating


Compare Robitussin Nasal Relief with other medications


  • Headache
  • Nasal Congestion
  • Sinus Symptoms


Where can I get more information?


  • Your pharmacist can provide more information about acetaminophen and phenylephrine.


Saturday, July 4, 2009

Avloclor




Avloclor may be available in the countries listed below.


UK matches:

  • Avloclor Tablets
  • Avloclor Tablets (SPC)

Ingredient matches for Avloclor



Chloroquine

Chloroquine phosphate (a derivative of Chloroquine) is reported as an ingredient of Avloclor in the following countries:


  • Egypt

  • Ethiopia

  • Ghana

  • Indonesia

  • Iraq

  • Israel

  • Jordan

  • Kenya

  • Kuwait

  • Lebanon

  • Libya

  • Malawi

  • Mozambique

  • Nigeria

  • Oman

  • Qatar

  • Saudi Arabia

  • Sudan

  • Syria

  • Tanzania

  • Uganda

  • United Arab Emirates

  • United Kingdom

  • Yemen

  • Zambia

  • Zimbabwe

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, July 1, 2009

Reca Uberex




Reca Uberex may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Reca Uberex



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Reca Uberex in the following countries:


  • Netherlands

International Drug Name Search

Saturday, June 27, 2009

Bromopan




Bromopan may be available in the countries listed below.


Ingredient matches for Bromopan



Bromopride

Bromopride is reported as an ingredient of Bromopan in the following countries:


  • Brazil

International Drug Name Search

Thursday, June 25, 2009

Torasemid TAD




Torasemid TAD may be available in the countries listed below.


Ingredient matches for Torasemid TAD



Torasemide

Torasemide is reported as an ingredient of Torasemid TAD in the following countries:


  • Germany

International Drug Name Search

Tuesday, June 23, 2009

Dobutamina Richet




Dobutamina Richet may be available in the countries listed below.


Ingredient matches for Dobutamina Richet



Dobutamine

Dobutamine hydrochloride (a derivative of Dobutamine) is reported as an ingredient of Dobutamina Richet in the following countries:


  • Argentina

International Drug Name Search

Tuesday, June 16, 2009

Cergem




Cergem may be available in the countries listed below.


Ingredient matches for Cergem



Gemeprost

Gemeprost is reported as an ingredient of Cergem in the following countries:


  • Germany

International Drug Name Search

Monday, June 15, 2009

Adco-Betamethasone




Adco-Betamethasone may be available in the countries listed below.


Ingredient matches for Adco-Betamethasone



Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Adco-Betamethasone in the following countries:


  • South Africa

International Drug Name Search

Wednesday, June 10, 2009

Anfree




Anfree may be available in the countries listed below.


Ingredient matches for Anfree



Flupentixol

Flupentixol dihydrochloride (a derivative of Flupentixol) is reported as an ingredient of Anfree in the following countries:


  • Bangladesh

Melitracen

Melitracen hydrochloride (a derivative of Melitracen) is reported as an ingredient of Anfree in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, May 31, 2009

Triflusal Stada




Triflusal Stada may be available in the countries listed below.


Ingredient matches for Triflusal Stada



Triflusal

Triflusal is reported as an ingredient of Triflusal Stada in the following countries:


  • Spain

International Drug Name Search

Wednesday, May 27, 2009

Argocian




Argocian may be available in the countries listed below.


Ingredient matches for Argocian



Hexoprenaline

Hexoprenaline sulfate (a derivative of Hexoprenaline) is reported as an ingredient of Argocian in the following countries:


  • Argentina

International Drug Name Search

Thursday, May 21, 2009

Venlafaxine Mylan




Venlafaxine Mylan may be available in the countries listed below.


Ingredient matches for Venlafaxine Mylan



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Venlafaxine Mylan in the following countries:


  • Belgium

International Drug Name Search

Thursday, May 14, 2009

Replens


Generic Name: topical emollients (TOP i kal ee MOL i ents)

Brand Names: Aloe Vesta Cream, AlphaSoft, AmeriPhor, Aqua Glycolic, Aqua Lube, Aquaphor, Aveeno, Baby Lotion, Baby Oil, Bag Balm, Baza-Pro, Beta Care, Blistex Lip Balm, Carmex, CarraKlenz, CeraVe, CeraVe AM, Cetaphil Lotion, Chap Stick, Citraderm, CoolBottoms, Corn Huskers Lotion, Curel Moisture Lotion, Derma Soothe, Dr Scholl's Essentials Cracked Skin Repair, Eucerin, Herpecin-L, K-Y Jelly, Keri Lotion, Lamisilk Heel Balm, Lubri-Soft, Lubriderm, Mederma, Moisturel, Natural Ice, NeutrapHor, NeutrapHorus Rex, Neutrogena Cleansing, Neutrogena Lotion, Nivea, Nutraderm, Pacquin, Phisoderm, Pretty Feet & Hands, Proshield Skincare Kit, Remedy 4-in-1 Cleansing Lotion, Replens, Secura, Sensi-Care, Soft Sense, St. Ives, Theraplex Lotion, Vaseline Intensive Care


What are Replens (topical emollients)?

Emollients are substances that moisten and soften your skin.


Topical (for the skin) emollients are used to treat or prevent dry skin. Topical emollients are sometimes contained in products that also treat acne, chapped lips, diaper rash, cold sores, or other minor skin irritation.


There are many brands and forms of topical emollients available and not all are listed on this leaflet.


Topical emollients may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Replens (topical emollients)?


You should not use a topical emollient if you are allergic to it. Topical emollients will not treat or prevent a skin infection.

Ask a doctor or pharmacist before using this medication if you have deep wounds or open sores, swelling, warmth, redness, oozing, bleeding, large areas of skin irritation, or any type of allergy.


What should I discuss with my healthcare provider before using Replens (topical emollients)?


You should not use a topical emollient if you are allergic to it. Topical emollients will not treat or prevent a skin infection.

Ask a doctor or pharmacist if it is safe for you to use this medicine if you have:



  • deep wounds or open sores;




  • swelling, warmth, redness, oozing, or bleeding;




  • large areas of skin irritation;




  • any type of allergy; or



  • if you are pregnant or breast-feeding.

How should I use Replens (topical emollients)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.


Clean the skin where you will apply the topical emollient. It may help to apply this product when your skin is wet or damp. Follow directions on the product label.


Shake the product container if recommended on the label.

Apply a small amount of topical emollient to the affected area and rub in gently.


If you are using a stick, pad, or soap form of topical emollient, follow directions for use on the product label.


Do not use this product over large area of skin. Do not apply a topical emollient to a deep puncture wound or severe burn without medical advice.

If your skin appears white or gray and feels soggy, you may be applying too much topical emollient or using it too often.


Some forms of topical emollient may be flammable and should not be used near high heat or open flame, or applied while you are smoking.

Store as directed away from moisture, heat, and light. Keep the bottle, tube, or other container tightly closed when not in use.


What happens if I miss a dose?


Since this product is used as needed, it does not have a daily dosing schedule. Seek medical advice if your condition does not improve after using a topical emollient.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while taking Replens (topical emollients)?


Avoid getting topical emollients in your eyes, nose, or mouth. If this does happen, rinse with water. Avoid exposure to sunlight or tanning beds. Some topical emollients can make your skin more sensitive to sunlight or UV rays.

Replens (topical emollients) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop using the topical emollient and call your doctor if you have severe burning, stinging, redness, or irritation where the product was applied.

Less serious side effects are more likely, and you may have none at all.


This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Replens (topical emollients)?


It is not likely that other drugs you take orally or inject will have an effect on topically applied products. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Replens resources


  • Replens Use in Pregnancy & Breastfeeding
  • Replens Support Group
  • 0 Reviews for Replens - Add your own review/rating


  • Biafine Emulsion MedFacts Consumer Leaflet (Wolters Kluwer)

  • Campath Monograph (AHFS DI)

  • Campral Monograph (AHFS DI)

  • Camptosar Monograph (AHFS DI)

  • Diabinese Monograph (AHFS DI)

  • Kinerase Cream MedFacts Consumer Leaflet (Wolters Kluwer)

  • Neosalus Foam MedFacts Consumer Leaflet (Wolters Kluwer)

  • Promiseb Cream MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Replens with other medications


  • Dry Skin


Where can I get more information?


  • Your pharmacist can provide more information about topical emollients.


Saturday, April 25, 2009

Cortimyk




Cortimyk may be available in the countries listed below.


Ingredient matches for Cortimyk



Hydrocortisone

Hydrocortisone is reported as an ingredient of Cortimyk in the following countries:


  • Norway

  • Sweden

Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Cortimyk in the following countries:


  • Norway

  • Sweden

International Drug Name Search

Friday, April 24, 2009

Sinaxar




Sinaxar may be available in the countries listed below.


Ingredient matches for Sinaxar



Methocarbamol

Methocarbamol is reported as an ingredient of Sinaxar in the following countries:


  • Colombia

International Drug Name Search

Monday, April 20, 2009

Bronchosedal Dextromethorphan HBR




Bronchosedal Dextromethorphan HBR may be available in the countries listed below.


Ingredient matches for Bronchosedal Dextromethorphan HBR



Dextromethorphan

Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Bronchosedal Dextromethorphan HBR in the following countries:


  • Belgium

International Drug Name Search

Saturday, April 18, 2009

Futuril




Futuril may be available in the countries listed below.


Ingredient matches for Futuril



Citalopram

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Futuril in the following countries:


  • Germany

International Drug Name Search

Thursday, April 16, 2009

Famotidine Hovid




Famotidine Hovid may be available in the countries listed below.


Ingredient matches for Famotidine Hovid



Famotidine

Famotidine is reported as an ingredient of Famotidine Hovid in the following countries:


  • Hong Kong

  • Singapore

International Drug Name Search

Tuesday, April 7, 2009

Laxoberal




Laxoberal may be available in the countries listed below.


Ingredient matches for Laxoberal



Sodium Picosulfate

Sodium Picosulfate is reported as an ingredient of Laxoberal in the following countries:


  • Chile

  • Denmark

  • Ireland

  • Japan

  • Malta

  • Norway

  • Sweden

Sodium Picosulfate monohydrate (a derivative of Sodium Picosulfate) is reported as an ingredient of Laxoberal in the following countries:


  • Germany

International Drug Name Search

Sunday, April 5, 2009

Folacite




Folacite may be available in the countries listed below.


Ingredient matches for Folacite



Folic Acid

Folic Acid is reported as an ingredient of Folacite in the following countries:


  • Indonesia

International Drug Name Search

Doxyveto




Doxyveto may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Doxyveto



Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxyveto in the following countries:


  • Belgium

  • Luxembourg

  • Poland

  • South Africa

Doxycycline hydrochloride (a derivative of Doxycycline) is reported as an ingredient of Doxyveto in the following countries:


  • South Africa

International Drug Name Search

Saturday, March 28, 2009

Fentavera




Fentavera may be available in the countries listed below.


Ingredient matches for Fentavera



Fentanyl

Fentanyl is reported as an ingredient of Fentavera in the following countries:


  • Germany

International Drug Name Search